Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension
- 1 January 1980
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 17 (3), 161-164
- https://doi.org/10.1007/bf00561894
Abstract
Summary The magnitude and duration of the antihypertensive effect of nifedipine were studied in 7 cases of moderate essential hypertension. In a double-blind crossover study, nifedipine 10 mg or a placebo were administered sublingually 4 times a day for 2 days, and the results were compared. Each dose of nifedipine reduced systolic and diastolic blood pressure by 14% both in the supine and upright positions. The antihypertensive action lasted for about 3 h and it was not cumulative. The reduction in blood pressure was associated with a temporary increase in heart rate. Administration of nifedipine 10 mg did not significantly raise plasma renin activity or plasma aldosterone. The drug was well tolerated and no side effects were detected.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation, 1979
- Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockadeAmerican Heart Journal, 1978
- Haemodynamic Effects of a Calcium Antagonistic Agent (Nifedipine) in Hypertension: Therapeutic ImplicationsClinical Science, 1978
- Nifedipine, a new antihypertensive with rapid actionClinical Pharmacology & Therapeutics, 1977
- Hypotensive Action and Increased Plasma Renin Activity by Ca2+ Antagonist (Nifedipine) in Hypertensive PatientsJapanese Heart Journal, 1976
- [Radioimmunoassays of aldosterone and plasma renin activity. Application to the diagnosis of primary aldosteronism].1973